HMGB1 concentration measurements in trauma patients: assessment of pre-analytical conditions and sample material

by William Ottestad, Ingrid N. Rognes, Erlend Skaga, Cassandra Frisvoll, Guttorm Haraldsen, Torsten Eken, Peter Lundbäck
Published 2019-12-01

Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells

by Artem Fayzullin, Cecilie J. Sandberg, Matthew Spreadbury, Birthe Mikkelsen Saberniak, Zanina Grieg, Erlend Skaga, Iver A. Langmoen, Einar O. Vik-Mo
Published 2019-01-01

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

by Erlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen, Cecilie J. Sandberg, Swapnil Potdar, Iver A. Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O. Vik-Mo
Published 2019-12-01

Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma

by Erlend Skaga, Evgeny Kulesskiy, Artem Fayzullin, Cecilie J. Sandberg, Swapnil Potdar, Aija Kyttälä, Iver A. Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O. Vik-Mo
Published 2019-06-01

A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation

by Kirsten Strømme Kierulf-Vieira, Cecilie Jonsgar Sandberg, Jo Waaler, Kaja Lund, Erlend Skaga, Birthe Mikkelsen Saberniak, Ioannis Panagopoulos, Petter Brandal, Stefan Krauss, Iver Arne Langmoen, Einar Osland Vik-Mo
Published 2020-06-01